Client Case Study: Revealing the Treatment Landscape and Patient Pathways in a new Market

A pharmaceutical company needed to launch a product into a new UK market where no targeted treatments or clinical pathways yet existed, and needed deeper market understanding to find opportunities. IQVIA deployed its Analytics Research Accelerator tool, using Longitudinal Patient Data (LPD) assets to trace patient journeys from initial diagnosis through first prescription in primary care. The analysis "uncovered several market opportunities for a New Product Launch in the UK," though specific quantitative results are not given on the page (published July 1, 2024); full detail is gated behind a PDF download.

The customer is anonymised in IQVIA’s own case study — not withheld by us.

IQVIA is the largest combined real-world-data and commercial-intelligence company in healthcare — its legacy IMS prescription and claims data underpins much of the industry's analytics.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.